1W Return
1M Return
6M Return
1Y Return
3Y Return
Start SIP in Concord Drugs Ltd
Stock Performance
52 Week Low - High
Today’s Low - High
Open
Prev. Close
Total Traded Value
Fundamental
Market Cap (in crs)
Face Value
Turnover (in lacs)
Key Metrics
Qtr Change %
41.89% Fall from 52W High
5.4
TTM PE Ratio
Negative PE TTM
-70.2
Price to Book Ratio
Low in industry
1.1
Dividend yield 1yr %
0
TTM PEG Ratio
Concord Drugs Ltd Key Financials
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
Concord Drugs Ltd Quarterly Revenue
| Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|
12.36 Cr | 11.69 Cr | 15.64 Cr | 12.78 Cr | 7.52 Cr |
Concord Drugs Ltd Yearly Revenue
| Mar 2024 | Mar 2023 |
|---|---|
44.93 Cr | 52.09 Cr |
Concord Drugs Ltd Quarterly Net Profit/Loss
| Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
|---|---|---|---|---|
0.04 Cr | 0.03 Cr | -0.34 Cr | -0.24 Cr | 0.56 Cr |
Concord Drugs Ltd Yearly Net Profit/Loss
| Mar 2024 | Mar 2023 |
|---|---|
0.47 Cr | 0.99 Cr |
Concord Drugs Ltd Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
Current Price
5Day EMA
36.10
10Day EMA
36.40
12Day EMA
36.50
20Day EMA
36.70
26Day EMA
36.70
50Day EMA
36.80
100Day EMA
37.10
200Day EMA
37.30
5Day SMA
35.80
10Day SMA
36.80
20Day SMA
36.60
30Day SMA
36.80
50Day SMA
36.90
100Day SMA
37.10
150Day SMA
37.40
200Day SMA
37.90
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 2470 Rs | 3314 Rs |
Week Rs | 7793 Rs | 8302 Rs |
Month Rs | 5420 Rs | 6680 Rs |
Resistance & Support
36.57
Pivot
Resistance
First Resistance
38.12
Second Resistance
40.50
Third Resistance
42.05
Support
First Support
34.19
Second support
32.64
Third Support
30.26
Relative Strength Index
44.17
Money Flow Index
65.60
MACD
-0.21
MACD Signal
-0.04
Average True Range
2.14
Average Directional Index
11.97
Rate of Change (21)
-3.41
Rate of Change (125)
-10.76
Similar stocks
Similar Stocks
Peer comparison
Compare
| Company | Market Price | Market Cap | 52W Low | 52W High |
|---|---|---|---|---|
Veerhealth Care Ltd. | - | - | - | |
Phaarmasia Ltd. | - | - | - | |
Zenith Healthcare Ltd. | - | - | - | |
Concord Drugs Ltd. | - | - | - | |
Murae Organisor Ltd. | - | - | - | |
Walpar Nutritions Ltd. | - | - | - | |
Vilin Bio Med Ltd. | - | - | - |
Concord Drugs Ltd Company background
Founded in: 1995
Managing director: S Nagi Reddy
Concord Drugs Limited, established in 1995, is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals, Dry Syrup powder) ,Tissue BioAdhesive, tablets, capsules and ophthalmic preparations and Readytofill Pellets. The principal activity of the Company is to manufacture licensed drugs based on the formulations approved. The Company has two manufacturing facilities license issued by The Government of Andhra Pradesh, Drugs Control Administration, and Hyderabad. State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Readytofill Pellets ensures the highest level of process integrity and product quality.The Company started with Finished Pharmaceutical Formulations and then diversified into Readytofill Pellets, to provide customers with endtoend solution to their various pharmaceutical product needs to commercial contract drug manufacturing. It is engaged in developing New products Viz MUPS (Multiple Unit Pellet System), Sustained Release, Modified Release pellets with Innovative Drug Delivery Technologies by utilizing best and latest processing machinery. It operates a state of the art, cGMP contract manufacturing FormulationFillFinish facility, providing comprehensive pharmaceutical development and manufacturing services for drug products.
Concord Drugs Ltd FAQs
How can I buy Concord Drugs Ltd shares?
You can easily buy Concord Drugs Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Open Demat Account
